Abingdon, United Kingdom

Elise Gadouleau

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Padlock Therapeutics, Inc., Ono Pharmaceutical Co., Ltd.. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elise Gadouleau. Retrieved from https://idiyas.com/inventor/elise-gadouleau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 14.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Oxfordshire, GB (2017 - 2020)
  • Abingdon, GB (2018 - 2024)

Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Elise Gadouleau

Introduction

Elise Gadouleau is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific disorders. With a total of five patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are the "Heteroaryl inhibitors of PAD4." This invention provides compounds that are useful as inhibitors of PAD4, along with compositions and methods for treating PAD4-related disorders. The significance of this work lies in its potential to address various health issues associated with PAD4.

Career Highlights

Elise has worked with notable companies in the pharmaceutical industry, including Padlock Therapeutics, Inc. and Ono Pharmaceutical Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research.

Collaborations

Throughout her career, Elise has collaborated with esteemed colleagues such as Rajesh Devraj and Gnanasambandam Kumaravel. These partnerships have played a crucial role in advancing her research and expanding her impact in the field.

Conclusion

Elise Gadouleau's innovative work and dedication to her field have established her as a key figure in pharmaceutical research. Her contributions continue to pave the way for advancements in treating PAD4-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…